Effect of bovine somatotropin on neutrophil functions and clinical symptoms during Streptococcus uberis mastitis.
The effect of recombinant bovine somatotropin (bST) on the chemiluminescence, diapedesis, and expression of adhesion receptors (CD11a, CD11b, CD18) of isolated polymorphonuclear leukocytes was studied. The plasma concentrations of insulin-like growth factor-I (IGF-I), bST, cortisol, and alpha-lactalbumin were also monitored. In addition, general and local clinical symptoms and the differentiation of circulating leukocytes were also studied during experimentally induced Streptococcus uberis mastitis in cows. Ten cows were infected with 500 cfu of S. uberis O140J in both left quarters. Five cows were subcutaneously treated with 500 mg of recombinant bST 7 d before and after infection, and 5 control cows received the excipient. General (fever, tachycardia, inappetance, and depression) and local symptoms (swelling, pain, firmness, and flecks in milk) were more acute, severe, and longer-lasting in control cows. Treatment with bST had no effect on chemiluminescence and diapedesis of circulating polymorphonuclear leukocytes and no effect on the expression of adhesion receptors. Recombinant bST induced significantly higher IGF-I and bST concentrations in plasma. The leukopenia observed after infection was less pronounced in the bST-treated cows, and the number of circulating band neutrophils and metamyelocytes was significantly lower in the treated group. The concentration of cortisol did not differ between both groups, but the blood concentration of alpha-lactalbumin significantly increased in both groups from 6 d after infection. These results showed that treatment with recombinant bST improves animal welfare by protecting the cows from severe local and general clinical symptoms during subsequent S. uberis mastitis, but that it has no effect on chemiluminescence, diapedesis, and the expression of adhesion receptors of circulating polymorphonuclear leukocytes.
Hoeben
D
D
Department of Physiology, Biochemistry and Biometrics, University of Ghent, Faculty of Veterinary Medicine, Merelbeke, Belgium.
Burvenich
C
C
Eppard
P J
PJ
Byatt
J C
JC
Hard
D L
DL
D000818:Animals; D018821:CD18 Antigens / Q000235:genetics; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000382:microbiology / Q000503:physiopathology; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D005434:Flow Cytometry; D013006:Growth Hormone / Q000494:pharmacology*; D008163:Luminescent Measurements; D016169:Lymphocyte Function-Associated Antigen-1 / Q000235:genetics; D016177:Macrophage-1 Antigen / Q000235:genetics; D008321:Mammary Glands, Animal / Q000473:pathology; D008414:Mastitis, Bovine / Q000097:blood / Q000382:microbiology / Q000503:physiopathology*; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013290:Streptococcal Infections / Q000097:blood / Q000503:physiopathology / Q000662:veterinary*
D018821:CD18 Antigens; D016169:Lymphocyte Function-Associated Antigen-1; D016177:Macrophage-1 Antigen; D011994:Recombinant Proteins; D013006:Growth Hormone